"Phew"??? It's mean there's no advancement in RAC's only IP which is why there won't be any interest even with "vultures". You even stated you wanted RAC to do CR to acquire other IP to increase their platform. I'm surprise RAC's MC is still above $200M compared to IMU given you guys haven't even conducted Ph1 clinical trial lol. That's why IMU is very undervalue right now.
Ann: Imugene Receives A$20 million for Convertible Notes Issuance, page-60
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $77.89M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 26.3¢ | $1.990M | 7.367M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 209631 | 9 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |